B
Baoju Wang
Researcher at Huazhong University of Science and Technology
Publications - 79
Citations - 4078
Baoju Wang is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Hepatitis B virus & T cell. The author has an hindex of 19, co-authored 76 publications receiving 2750 citations. Previous affiliations of Baoju Wang include Union Hospital & Tongji Medical College.
Papers
More filters
Journal ArticleDOI
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.
Jing Liu,Sumeng Li,Jia Liu,Boyun Liang,Xiaobei Wang,Hua Wang,Wei Li,Qiaoxia Tong,Jianhua Yi,Lei Zhao,Lijuan Xiong,Chunxia Guo,Jin Tian,Jinzhuo Luo,Jinghong Yao,Ran Pang,Hui Shen,Cheng Peng,Ting Liu,Qian Zhang,Jun Wu,Ling Xu,Sihong Lu,Baoju Wang,Zhihong Weng,Chunrong Han,Huabing Zhu,Ruxia Zhou,Helong Zhou,Xiliu Chen,Pian Ye,Bin Zhu,Lu Wang,Wenqing Zhou,Shengsong He,Yong-Wen He,Shenghua Jie,Ping Wei,Jianao Zhang,Yinping Lu,Weixian Wang,Li Zhang,Ling Li,Fengqin Zhou,Jun Wang,Jun Wang,Ulf Dittmer,Ulf Dittmer,Mengji Lu,Mengji Lu,Yu Hu,Dongliang Yang,Xin Zheng +52 more
TL;DR: The degree of lymphopenia and a proinflammatory cytokine storm is higher in severe COVID-19 patients than in mild cases, and is associated with the disease severity.
Posted ContentDOI
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
Jing Liu,Sumeng Li,Jia Liu,Boyun Liang,Xiaobei Wang,Hua Wang,Wei Li,Qiaoxia Tong,Jianhua Yi,Lei Zhao,Lijuan Xiong,Chunxia Guo,Jin Tian,Jinzhuo Luo,Jinghong Yao,Ran Pang,Hui Shen,Cheng Peng,Ting Liu,Qian Zhang,Jun Wu,Ling Xu,Sihong Lu,Baoju Wang,Zhihong Weng,Chunrong Han,Huabing Zhu,Ruxia Zhou,Helong Zhou,Xiliu Chen,Pian Ye,Bin Zhu,Shengsong He,Yong-Wen He,Shenghua Jie,Ping Wei,Jianao Zhang,Yinping Lu,Weixian Wang,Li Zhang,Ling Li,Fengqin Zhou,Jun Wang,Jun Wang,Ulf Dittmer,Ulf Dittmer,Mengji Lu,Mengji Lu,Yu Hu,Dongliang Yang,Xin Zheng +50 more
TL;DR: The degree of lymphopenia and a proinflammatory cytokine storm is higher in severe COVID-19 patients than in mild cases, and is associated with the disease severity.
Journal ArticleDOI
Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.
Jia Liu,Xin Zheng,Qiaoxia Tong,Wei Li,Baoju Wang,Kathrin Sutter,Kathrin Sutter,Mirko Trilling,Mirko Trilling,Mengji Lu,Mengji Lu,Ulf Dittmer,Ulf Dittmer,Dongliang Yang +13 more
TL;DR: A brief introduction to the pathology and pathogenesis of SARS‐CoV and MERS‐ coV is provided and extrapolate this knowledge to the newly identified 2019‐nCoV.
Journal ArticleDOI
Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection.
Jia Liu,Ejuan Zhang,Zhiyong Ma,Weimin Wu,Anna D. Kosinska,Xiaoyong Zhang,Inga Möller,Pia L. Seiz,Dieter Glebe,Baoju Wang,Dongliang Yang,Mengji Lu,Michael Roggendorf +12 more
TL;DR: In vivo blockade of PD-1/PD-L1 pathway on CD8 T cells, in combination with ETV treatment and DNA vaccination, potently enhanced the function of virus-specific T cells and led to sustained immunological control of viral infection, anti-WHs antibody development and complete viral clearance in some woodchucks.
Journal ArticleDOI
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19.
Jun Wu,Boyun Liang,Cunrong Chen,Hua Wang,Yaohui Fang,Shu Shen,Xiaoli Yang,Baoju Wang,Liangkai Chen,Chen Qi,Yang Wu,Jia Liu,Xuecheng Yang,Wei Li,Bin Zhu,Wenqing Zhou,Huan Wang,Shumeng Li,Sihong Lu,Di Liu,Huadong Li,Adalbert Krawczyk,Mengji Lu,Mengji Lu,Dongliang Yang,Fei Deng,Ulf Dittmer,Ulf Dittmer,Mirko Trilling,Mirko Trilling,Xin Zheng +30 more
TL;DR: In this paper, the authors quantify immunoglobulin M (IgM) and G(IgG) antibodies recognizing the SARS-CoV-2 receptor-binding domain (RBD) of the spike (S) or the nucleocapsid (N) protein, and neutralizing antibodies during a period of 6 months from COVID-19 disease onset.